Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.03 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.03 |